Zusammenfassung
Gemeinsames biologisches Merkmal von Krebserkrankungen (malignen Neoplasien) ist die unkontrollierte, autonome Proliferation einer genetisch mutierten Zelle mit Wucherung in gesundes Gewebe, ggf. Lymphknotenbefall und Metastasenbildung. Im Rahmen der multifaktoriellen Genese von Krebserkrankungen, die gehäuft im Alter (Hauptrisikofaktor) auftreten und u. a. in Deutschland die zweithäufigste Todesursache darstellen, sind (neben seltener wirksamen heriditären Faktoren) exogene Faktoren relevant, nämlich chemische und physikalische Kanzerogene, Viren, Immundefekte und auch Risikoverhaltensweisen. Psychobiologische Prozesse (wie die stressinduzierte Einwirkung von Stresshormonen auf die Mikroumgebung des Tumors) sind bei der Tumorabwehr und -entwicklung von Bedeutung. Es lassen sich (bereits aus methodischen Gründen) keine prädisponierenden Persönlichkeitsmerkmale nachweisen. In prospektiven Längsschnittstudien zeigen sich einzelne Assoziationen zwischen psychosozialen Stressoren respektive Copingfähigkeiten und Krebsinzidenz sowie -mortalität. Verhaltensmedizinisch wichtig ist die angemessene Risikokommunikation zu Screeningtests. Erfolgreiche psychologische Interventionen sind das kognitiv-behaviorale Stressmanagement, aber auch Techniken der klassischen Konditionierung z. B. zur Therapie antizipatorischer Übelkeit bzw. Erbrechen im Rahmen der Chemotherapie.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Abbey, G., Thompson, S. B. N., Hickish, T., & Heathcote, D. (2014). A meta-analysis of prevalence rates and moderating factors for cancer-related post-traumatic stress disorder. Psycho-Oncology, 24(4):371–381. doi:10.1002/pon.3654.
Andersen, B. L., Farrar, W. B., Golden-Kreutz, D., Kutz, L. A., MacCallum, R., Courtney, M. E., & Glaser, R. (1998). Stress and immune responses after surgical treatment for regional breast cancer. Journal of the National Cancer Institute, 90, 30–36.
Andersen, B. L., Yang, H.-C., Farrar, W. B., Golden-Kreutz, D. M., Emery, C. F., Thornton, L. M., Young, D. C., & Carson, W. E. (2008). Psychological intervention improves survival for breast cancer patients. Cancer, 113, 3450–3458.
Antoni, M. H. (2013). Psychosocial intervention effects on adaptation, disease course and biobehavioral processes in cancer. Brain, Behavior and Immunity, 30, 88–98.
Antoni, M. H., Lutgendorf, S. K., Cole, S. W., Dhabhar, F. S., Sephton, S. E., McDonald, P. G., Stefanek, M., & Sood, A. K. (2006). The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nature Reviews Cancer, 6, 240–248.
Bovbjerg, D. H., Redd, W. H., Jacobsen, P. B., Manne, S. L., Taylor, K. L., Surbone, A., & Hakes, T. B. (1992). An experimental analysis of classically conditioned nausea during cancer chemotherapy. Psychosomatic Medicine, 54, 623–637.
Bower, J. E., & Lamkin, D. M. (2013). Inflammation and cancer-related fatigue: Mechanisms, contributing factors, and treatment implications. Brain, Behavior and Immunity, 30, 48–57.
Burish, T. G. (2000). The role of behavioral and psychosocial science in reducing cancer morbidity and mortality. The Oncologist, 5, 263–266.
Chida, Y., Hamer, M., Wardle, J., & Steptoe, A. (2008). Do stress-related psychosocial factors contribute to cancer incidence and survival? Nature Clinical Practice Oncology, 5, 466–475.
Cleeland, C. S., Bennett, G. J., Dantzer, R., Dougherty, P. M., Dunn, A. J., Meyers, C. A., Miller, A. H., Payne, R., Reuben, J. M., Wang, X. S., & Lee, B. N. (2003). Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunological model of cancer symptoms. Cancer, 97, 2919–2925.
Corthay, A. (2014). Does the immune system naturally protect against cancer? Frontiers in Immunology, 5(Article 197), 1–8. doi:10.3389/fimmu.2014.00197.
Costanzo, E. S., Lutgendorf, S. K., Sood, A. K., Anderson, B., Sorosky, J., & Lubaroff, D. M. (2005). Psychosocial factors and interleukin-6 among women with advanced ovarian cancer. Cancer, 104, 305–313.
Cruess, D. G., Antoni, M. H., McGregor, B. A., Kilbourn, K. M., Boyers, A. E., Alferi, S. M., Carver, C. S., & Kumar, M. (2000). Cognitive-behavioral stress management reduces serum cortisol by enhancing benefit finding among women being treated for early stage breast cancer. Psychosomatic Medicine, 62, 304–308.
Danaei, van der Hoorn, Lopez, Murray, C. J. L., Ezzati, & the Comparative Risk Assessment collaborating group (2005). Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet, 366, 1784–1793.
Dantzer, R., O’Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008). From inflammation to sickness and depression: when the immune system subjugates the brain. Nature Reviews Neuroscience, 9, 46–57.
Derogatis, L. R., Morrow, G. R., Fetting, J., Penman, D., Piasetsky, S., Schmale, A. M., Henrichs, M., & Carnicke, C. L. M. (1983). The prevalence of psychiatric disorders among cancer patients. Journal of the American Medical Association, 249, 751–757.
Eisman, E. A., Lush, E., & Sephton, S. E. (2010). Circadian effects in cancer-relevant psychoneuroendocrine and immune pathways. Psychoneuroendocrinology, 35, 963–976.
Erbar, P. (2000). Onkologie. Stuttgart: Schattauer.
European Code against cancer. http://www.europeancancerleagues.org/ewac/european-code-against-cancer.html (Abgerufen 05.01.2014)
Fawzy, F. I., Fawzy, N. W., Arndt, L. A., & Pasnau, R. O. (1995). Critical review of psychosocial interventions in cancer care. Archives of General Psychiatry, 52, 100–113.
Ganz, P. A., Bower, J. E., Kwan, L., Castellon, S. A., Silverman, D. H. S., Geist, C., Breen, E. C., Irwin, M. R., & Cole, S. W. (2013). Does tumor necrosis factor-alpha (TNF-α) play a role in post-chemotherapy cerebral dysfunction? Brain, Behavior and Immunity, 30, 99–108.
Garssen, B. (2004). Psychological factors and cancer development: Evidence after 30 years of research. Clinical Psychology Review, 24, 315–338.
Garssen, B., & Goodkin, K. (1999). On the role of immunological factors as mediators between psychosocial factors and cancer progression. Psychiatry Research, 85, 51–61.
Gigerenzer, G. (2014). Breast cancer screening pamphlets mislead women. British Medical Journal, 348(g2636), 2636. doi:10.1136/bmj.g2636.
Globocan (2012). Estimated cancer incidence, prevalence, and mortality worldwide in 2012. World health Organization. International Agency for Research of Cancer. http://globocan.iarc.fr/Default.aspx. Zugegriffen: 16.12.2014
Goodwin, P. J., Leszcz, M., Ennis, M., Koopmans, J., Vincent, L., Guther, H., Drysdale, E., Hundleby, M., Chochinov, H. M., Navarro, M., Speca, M., & Hunter, J. (2001). The effect of group psychosocial support on survival in metastatic breast cancer. The New England Journal of Medicine, 345, 1719–1726.
Gøtzsche, P. C., & Jørgensen, K. J. (2013). Screening for breast cancer with mammography. Cochrane Database of Systematic Reviews, CD001877(6). doi:10.1002/14651858.CD001877.pub5.
Greer, S., Morris, T., & Pettingale, K. W. (1979). Psychological response to breast cancer: effect on outcome. The Lancet, 2(8146), 785–787.. October 13
Grulke, N., & Larbig, W. (2001). Verhaltensmedizin und Krebs. In H. Flor, K. Hahlweg, & N. Birbaumer (Hrsg.), Anwendungen der Verhaltensmedizin Enzyklopädie der Psychologie, (Bd. D/II/Band 4, S. 515–589). Göttingen: Hogrefe.
Hasenbring, M., & Schulz, K.-H. (1994). Onkologie. In W.-D. Gerber, H.-D. Basler, & U. Tewes (Hrsg.), Medizinische Psychologie (S. 175–189). München: Urban & Schwarzenberg.
Hassan, S., Karpova, Y., Baiz, D., Yancey, D., Pullikuth, A., Flores, A., Register, T., Cline, M. J., D’Agostino, R. D., Danial, N., Datta, S. R., & Kulik, G. (2013). Behavioral stress accelerates prostate cancer development in mice. Journal of Clinical Investigation, 123, 874–886.
Ilic, D., Neuberger, M. M., Djulbegovic, M., & Dahm, P. (2013). Screening for prostate cancer. Cochrane Database of Systematic Reviews, CD004720(1). doi:10.1002/14651858.CD004720.pub3.
Imai, K., Matsuyama, S., Miyake, S., Suga, K., & Nakachi, K. (2000). Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11–year follow-up study of a general population. Lancet, 356, 1795–1799.
Janssen, E., Waters, E. A., van Osch, L., Lechner, L., & de Vries, H. (2014). The importance of affectively-laden beliefs about health risks: the case of tabacco use and sun protection. Journal of Behavioral Medicine, 37, 11–21.
Jokela, M., Batty, G. D., Hintsa, T., Elovainio, M., Hakulinen, C., & Kivimäki, M. (2014). Is personality associated with cancer incidence and mortality? An individual-participant meta-analysis of 2156 incident cancer cases among 42 843 men and women. British Journal of Cancer, 110, 1820–1824.
Kamen, C., Tejani, M. A., Chandwani, K., Janelsins, M., Peoples, A. R., Roscoe, J. A., & Morrow, G. R. (2014). Anticipatory nausea and vomiting due to chemotherapy. European Journal of Pharmacology, 722, 172–179.
Kiecolt-Glaser, J. K., & Glaser, R. (1999). Psychoneuroimmunology and cancer: Fact or fiction? European Journal of Cancer, 35, 1603–1607.
Levy, S. M., Herberman, R. B., Whiteside, T., Sanzo, K., Lee, J., & Kirkwood, J. (1990). Perceived social support and tumor estrogen/progesterone receptor status as predictors of natural killer cell activity in breast cancer patients. Psychosomatic Medicine, 52, 73–85.
Luebbert, K., Dahme, B., & Hasenbring, M. (2001). The effectiveness of relaxation training in reducing treatment-related symptoms and improving emotional adjustment in acute non-surgical cancer treatment: A meta-analytical review. Psycho-Oncology, 10, 490–502.
Lutgendorf, S. K., Johnsen, E. L., Cooper, B., Anderson, B., Sorosky, J. I., Buller, R. E., & Sood, A. K. (2002). Vascular endothelial growth factor and social support in patients with ovarian carcinoma. Cancer, 95, 808–815.
McDonald, P. G., O´Connell, M., & Lutgendorf, S. K. (2013). Psychoneuroimmunology and cancer: A decade of discovery, paradigm shifts, and methodological innovations. Brain, Behavior and Immunity, 30, 1–9.
Morfeld, M., Kirchberger, I., & Bullinger, M. (2011). SF-36 Fragebogen zum Gesundheitszustand. Göttingen: Hogrefe.
Nausheen, B., Gidron, Y., Peveler, R., & Modd-Morris, R. (2009). Social support and cancer progression: A systematic review. Journal of Psychosomatic Research, 67, 403–415.
Pettingale, K. W., Morris, T., Greer, S., & Haybittle, J. L. (1985). Mental attitudes to cancer: An additional prognostic factor. The Lancet, 1(8431), 750.. March 30
Robert Koch-Institut, & Gesellschaft der epidemiologischen Krebsregister in Deutschland e. V. (Hrsg.). (2013). Krebs in Deutschland 2009/2010 (9.. Aufl.). Berlin: ruksaldruck.
Schulz, W. A. (2005). Molecular biology of human cancers. Dordrecht: Springer.
Sephton, S. E., Sapolsky, R. M., Kraemer, H. C., & Spiegel, D. (2000). Diurnal cortisol rhythm as a predictor of breast cancer survival. Journal of the National Cancer Institute, 92, 994–1000.
Smith, M. Y., Redd, W. H., Peyser, C., & Vogl, D. (1999). Post-traumatic stress disorder in cancer: A review. Psycho-Oncology, 8, 521–537.
Spiegel, D., & Kato, P. M. (1996). Psychosocial influences on cancer incidence and progression. Harvard Review of Psychiatry, 4, 10–26.
Spiegel, D., Bloom, J. R., Kraemer, H. C., & Gottheil, E. (1989). Effect of psychosocial treatment on survival of patients with metastatic breast cancer. The Lancet, 2(8668), 888–891.. October 14
Stockhorst, U., Wiener, J. A., Klosterhalfen, S., Klosterhalfen, W., Aul, C., & Steingrüber, H.-J. (1998). Effects of overshadowing on conditioned nausea in cancer patients: an experimental study. Physiology & Behavior, 64, 743–753.
Stockhorst, U., Spennes-Saleh, S., Körholz, D., Göbel, U., Schneider, M. E., Steingrüber, H.-J., & Klosterhalfen, S. (2000). Anticipatory symptoms and anticipatory immune responses in pediatric cancer patients receiving chemotherapy: Features of a classically conditioned response? Brain, Behavior and Immunity, 14, 198–218.
Traa, M. J., De Vries, J., Bodenmann, G., & Den Oudsten, B. L. (2015). Dyadic coping and relationship functioning in couples coping with cancer: A systematic review. British Journal of Health Psychology, 20(1):85–114. doi:10.1111/bjhp.12094.
Vineis, P., & Wild, C. P. (2014). Global cancer patterns: causes and prevention. Lancet, 383, 549–557.
Visintainer, M. A., Volpicelli, J. R., & Seligman, M. E. P. (1982). Tumor rejection in rats after inescapable or escapable shock. Science, 216, 437–439.
Volden, P. A., & Conzen, S. D. (2013). The influence of glucocorticoid signaling on tumor progression. Brain, Behavior and Immunity, 30, 26–31.
Wagener, C., & Müller, O. (2010). Molekulare Onkologie. Stuttgart: Thieme.
Wegwarth, O., Schwartz, L. M., Woloshin, A., Gaissmaier, W., & Gigerenzer, G. (2012). Do physicians understand cancer screening statistics? A national survey of primary care physicians in the United States. Annals of Internal Medicine, 156, 340–349.
WHO Library Cataloguing-in-Publication Data (2011). Global status report on noncommunicable diseases 2010. Geneva: WHO Press. http://www.who.int/nmh/publications/ncd_ report2010/en/
Woolf, S. H. (2001). The accuracy and effectiveness of routine population screening with mammography, prostate-specific antigen, and prenatal ultrasound. International Journal of Technology Assessment in Health Care, 17, 275–304.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Stockhorst, U. (2016). Krebserkrankungen. In: Ehlert, U. (eds) Verhaltensmedizin. Springer-Lehrbuch. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-48035-9_9
Download citation
DOI: https://doi.org/10.1007/978-3-662-48035-9_9
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-48034-2
Online ISBN: 978-3-662-48035-9
eBook Packages: Psychology (German Language)